Crystal structure of methyl 4-{[4-(4-cyanobenzamido)phenyl]amino}benzofuro[2,3-d]pyrimidine-6-carboxylate, C26H17N5O4
Author:
Li Pei-Xuan1ORCID, Hui Wei2, Jing Qin-Qin3
Affiliation:
1. College of Safety Science and Engineering, Xi’an University of Science and Technology , Xi’an 710054 , China 2. China Northwest Architecture Design and Research Institute Co. LTD , Xi’an 710018 , China 3. Yanan Energy and Chemical Group Co., LTD , Yan’An , China
Abstract
Abstract
C46H38N10S2, triclinic,
P
1
‾
$P\overline{1}$
(no. 2), a = 8.9297(12) Å, b = 10.9926(15) Å, c = 12.6758(18) Å, α = 104.532(2)°, β = 96.312(2)°, γ = 112.398(2)° V = 1083.8(3) Å3, Z = 2, R
gt
(F) = 0.0398, wR
ref
(F
2) = 0.1195, T = 296(2) K.
Publisher
Walter de Gruyter GmbH
Subject
Inorganic Chemistry,Condensed Matter Physics,General Materials Science
Reference11 articles.
1. Agilent Technologies. CrysAlispro Software system (version 1.171.35.15); Agilent Technologies UK Ltd: Oxford, UK, 2011. 2. Sheldrick, G. M. SHELXTL – Integrated space-group and crystal-structure determination. Acta Crystallogr. 2015, A71, 3–8; https://doi.org/10.1107/s2053273314026370. 3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218. 4. Abd, E. H. S. R., Lasheen, D. S., Hassan, M. A., Abouzid, K. A. M. Design and synthesis of 4-anilinothieno[2,3-d]pyrimidine-based compounds as dual EGFR/HER-2 inhibitors. Arch. Pharm. 2016, 349, 827–847; https://doi.org/10.1002/ardp.201600197. 5. Ding, H.-G., Cai, Z.-Q., Hou, L., Hu, Z.-Q., Jin, Z.-S., Xu, D., Cao, H., Meng, M.-M., Xie, Y.-H., Zheng, D.-Q. Synthesis and evaluation of some novel 6-substituted quinazoline derivatives as antitumor agents. J. Chem. Soc. Pakistan 2014, 87, 782–793.
|
|